Atossa Therapeutics Share Price Today (NASDAQ: ATOS)
Atossa Therapeutics share price is $0.83 & ₹71.43 as on 14 Jun 2025, 01.29 hrs IST
$0.83
Market is closed - opens 7 PM, 16 Jun 2025
View live Atossa Therapeutics share price in Dollar and Rupees. Guide to invest in Atossa Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atossa Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Atossa Therapeutics share price movements
- Today's Low: $0.82Today's High: $0.84
1.69%
Downside
Day's Volatility :3.06%
Upside
1.4%
- 52 Weeks Low: $0.5552 Weeks High: $1.66
33.42%
Downside
52 Weeks Volatility :66.71%
Upside
50.0%
Atossa Therapeutics (ATOS) Returns
Atossa Therapeutics (ATOS) Key Statistics
in dollars & INR
How to invest in Atossa Therapeutics Stock (ATOS) from India?
It is very easy for Indian residents to invest directly in Atossa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atossa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atossa Therapeutics or ATOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atossa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Atossa Therapeutics shares which would translate to 1.037 fractional shares of Atossa Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Atossa Therapeutics, in just a few clicks!
Returns in Atossa Therapeutics (ATOS) for Indian investors in Rupees
The Atossa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atossa Therapeutics investment value today
Current value as on today
₹72,205
Returns
Returns from Atossa Therapeutics Stock
Dollar Returns*
₹3,039 (+3.04%)
Indian investors sentiment towards Atossa Therapeutics (ATOS)
Global Institutional Holdings in Atossa Therapeutics
BlackRock Inc
7.45%
Vanguard Group Inc
5.10%
Geode Capital Management, LLC
2.20%
Renaissance Technologies Corp
1.44%
State Street Corp
1.34%
UBS Group AG
0.87%
Analyst Recommendation on Atossa Therapeutics
Buy
90%Buy
10%Hold
0%Sell
Based on 10 Wall street analysts offering stock ratings for Atossa Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Atossa Therapeutics Stock (ATOS)
What analysts predicted
Upside of 577.71%
Target:
$5.63
Current:
$0.83
Insights on Atossa Therapeutics Stock (Ticker Symbol: ATOS)
Price Movement
In the last 1 month, ATOS stock has moved down by -19.0%ATOS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 122.2%ATOS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.3% return, outperforming this stock by 148.5%
Atossa Therapeutics Technicals Summary
Sell
Neutral
Buy
Atossa Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Atossa Therapeutics (ATOS) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -15.33% | -22.01% | -30.46% | -19.76% | -72.73% |
 | -9.61% | -27.05% | -48.98% | -5.77% | -10.46% |
 | 19.44% | 52.93% | 65.87% | 97.21% | 57.25% |
 | 4.88% | -2.68% | -5.24% | 79.7% | 70.13% |
 | 8.48% | 26.01% | 91.68% | 126.98% | 139.48% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -0.23 | -0.35 | -0.22 | NA | 0.51 |
| 13.31 | 13.31 | 1.07 | 35.45 | 0.16 | 0.07 | 0.01 | 277.5 |
| NA | NA | NA | 1.39 | -0.11 | -0.03 | NA | 32.42 |
| 32.84 | NA | 2.66 | 18.0 | -0.06 | 0.12 | NA | 64.2 |
| NA | NA | -0.49 | 0.93 | -15.01 | -0.02 | NA | 0.89 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $111.4M | -72.73% | NA | 0.0% |
| Buy | $56.0B | -10.46% | 13.31 | 31.94% |
| NA | $32.0B | 57.25% | NA | -9.4% |
| Buy | $116.2B | 70.13% | 32.84 | -8.91% |
| Buy | $38.9B | 139.48% | NA | -11.49% |
About Atossa Therapeutics
What is Atos?
Atossa Therapeutics, Inc., popularly called Atos, is a clinical-stage biopharmaceutical company focused on developing innovative treatments in oncology, particularly for breast cancer. It was founded in 2008 and is headquartered in Seattle, Washington. The company was formerly known as Atossa Genetics Inc. before rebranding to Atossa Therapeutics, Inc. in January 2020.
What does Atos do?
Atossa develops targeted therapies for breast cancer and related conditions with a focus on areas of unmet medical need. Its lead candidate, oral (Z)-endoxifen, is an active metabolite of tamoxifen currently in Phase II clinical trials for breast cancer treatment and prevention. The company is also advancing immunotherapy programs, including chimeric antigen receptor (CAR) therapies, to expand its pipeline into other oncology areas.
Atos Products and Programs
| Products/Programs | Description |
| Oral (Z)-Endoxifen | Phase II-stage drug for treatment and prevention of hormone-receptor positive breast cancer |
| Immunotherapy Programs | Development of CAR-based therapies to target cancerous cells |
| Oncology R&D | Focus on novel, targeted treatments for breast cancer and related indications |
| Clinical Trials | Multiple Phase I/II trials evaluating safety and efficacy of pipeline therapies |
Management People of Atossa Therapeutics
Important FAQs about investing in ATOS Stock from India :
Can Indians buy Atossa Therapeutics shares?
Yes, Indians can invest in the Atossa Therapeutics (ATOS) from India.
With INDmoney, you can buy Atossa Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Atossa Therapeutics at zero transaction cost.
How can I buy Atossa Therapeutics shares from India?
It is very easy to buy Atossa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Atossa Therapeutics (ATOS) be purchased?
Yes, you can buy fractional shares of Atossa Therapeutics with INDmoney app.
What are the documents required to start investing in Atossa Therapeutics stocks?
To start investing in Atossa Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What is Atossa Therapeutics share price today?
Atossa Therapeutics share price today stands at $0.83, Open: $0.84 ; Previous Close: $0.86 ; High: $0.84 ; Low: $0.82 ; 52 Week High: $1.66 ; 52 Week Low: $0.55.
The stock opens at $0.84, after a closing price of $0.86. The stock reached a daily high of $0.84 and a low of $0.82, with a 52-week high of $1.66 and a 52-week low of $0.55.
What are today’s High and Low prices of Atossa Therapeutics Stock (ATOS)?
Today’s highest price of Atossa Therapeutics (ATOS) is $0.84.
Today’s lowest price of Atossa Therapeutics (ATOS) is $0.82.
What is the 52 Week High and Low Range of Atossa Therapeutics Stock (ATOS)?
52 Week High
$1.66
52 Week Low
$0.55
What are the historical returns of Atossa Therapeutics (ATOS)?
1 Month Returns
-15.33%
3 Months Returns
-22.01%
1 Year Returns
-30.46%
5 Years Returns
-72.73%
What is today's market capitalisation of Atossa Therapeutics?
Who is the Chief Executive Officer (CEO) of Atossa Therapeutics ?
Discover More
Tpi Composites, Inc.$1.08
-13.6%
Flotek Industries Inc$16.01
-2.26%
Cardio Diagnostics Holdings Inc$4.06
+2.78%
Ab Tax-aware Short Duration Municipal Etf$25.04
-0.04%
Titan Machinery Inc$19.30
-2.43%
- Cp High Yield Trend Etf
$21.42
-1.38%
Bondbloxx Usd Hy Bond Cons Cyclicals Sctr Etf$36.86
+0.08%
- Crane Harbor Acquisition-rts
$0.21
+0.0%